How to Reach & Engage HCPs [Infographic]

Over a year ago, in April 2019, we debuted our end-to-end HCP advertising platform to a select few beta partners. Just 5 months later, DeepIntent formally announced our innovation to the world.

We had officially launched the first-ever healthcare platform that could match NPI and digital IDs to clinical, behavioral, and contextual data in real-time. HCP marketers finally had a true end-to-end solution that allowed them to match and segment high-value HCPs, measure NPI-level performance, and optimize campaigns in-flight – all within a single programmatic platform. 

Since then, our platform gained industry recognition for innovation, and – much to our clients’ delight – has consistently out-performed other HCP advertising solutions. Here’s how:

Learn more about our HCP Audience solutions or book a demo here

More Insights

Driving NBRx and Improving AQ with Outcomes
Blog Post
Driving NBRx and Improving AQ: How DeepIntent Outcomes Delivers for Pharma Advertisers
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big thing...
Read More
Innovating With Intent 2023- The state of convergent TV
Blog Post
The State of Convergent TV: 3 Takeaways from Our Innovating with Intent Event
In its true form, convergence refers to the shift from analog to digital, something that’s been happening for many years. By 2022, Leichtman Research Group...
Read More
Switching from linear TV to CTV
Blog Post
Three Considerations for Healthcare Marketers Switching from Linear TV to CTV
For decades, traditional or linear TV has dominated the budgets of pharma advertisers. To meet industry recommendations developed decades ago, which call for audience sizes...
Read More
Back to Top